GLP1R and type 2 diabetes mellitus: Short-term treatment with vildagliptin and sitagliptin, selective DPP-4 inhibitors, has been shown to reduce postprandial lipaemia in T2DM [20, 21], presumably by inhibiting the inactivation of endogenous GLP-1 by DPP-4.